Abstract

Acellular amniotic membrane (AM) has been studied, with promising results on the reconstruction of lesioned tissues, and has become an attractive approach for tracheal repair. This study aimed to evaluate the repair of the trachea with human umbilical cord mesenchymal stem cells (hucMSCs) differentiated in chondrocytes, grown on an experimental model. Tracheal defects were induced by surgical tracheostomy in 30 New Zealand rabbits, and the acellular amniotic membrane, with or without cells, was covering the defect. The hucMSCs were isolated and cultivated with chondrogenic differentiation over the culture of 14 days, and then grown on the AM. In this study, the AM was biocompatible and hucMSCs differentiated into chondrocytes. Our results demonstrated an important role for AM with cultured cells in the promotion of immature collagen, known to produce tissue regeneration. In addition, cartilaginous tissue was found at the tracheal defects, demonstrated by immunohistology results. This study suggests that this biomaterial implantation can be an effective future therapeutic alternative for patients with tracheal injury.

Highlights

  • Stenosis of the trachea is a major cause of morbidity and mortality after endotracheal intubation or tracheostomy [1]

  • This study aimed to assess the potential improvement of trachea function using human umbilical cord mesenchymal stem cells (hucMSCs) differentiation on an acellular amniotic membrane for tissue repair in the tracheostomy model

  • All rabbits were housed under standard conditions with food and water ad libitum on a 12-h day/night cycle in individual cages, throughout the experimental period

Read more

Summary

Introduction

Stenosis of the trachea is a major cause of morbidity and mortality after endotracheal intubation or tracheostomy [1]. Several deleterious effects are known to occur on the tracheal mucosa, including inflammation during trauma, granulation tissue formation, fibrosis, or scar formation [2]. It is known that the trachea can be reduced by half in adults and to by a third in small children being the gold standard treatment the end-to-end primary surgical anastomosis. When the defect exceeds these limits, it has been tried to replace the trachea using organic and artificial tubes that causes severe complications such as infection, extrusion, obstruction, stenosis and chronic rejection [3]. There are many obstacles to overcome, such as the rapid degradation of growth factors [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call